Patient Monitoring Market to Reach $76 Billion by 2031

Driven by the rising global prevalence of chronic conditions like diabetes and cardiovascular disease, the patient monitoring devices sector is set for steady expansion. Analysts project the market will grow from $55.60 billion in 2026 to $76.11 billion by 2031, representing a compound annual growth rate of 6.4%.

The surge in demand is fueled by an aging population and a strategic shift toward preventive and remote healthcare. Hospitals and clinics remain the primary adopters of these technologies, utilizing multiparameter monitors and cardiac systems to manage intensive care requirements and improve patient outcomes. Blood glucose monitoring devices currently lead the market segment, bolstered by wearable technology, smartphone connectivity, and the integration of cloud-based data for real-time disease management.

Geographically, the Asia-Pacific region is emerging as the fastest-growing market, with India expected to see a 9.1% growth rate. This expansion stems from improved healthcare infrastructure and a growing patient pool in countries such as China and Japan. Major industry players, including Medtronic, Abbott Laboratories, and GE HealthCare, continue to focus on innovation to meet the demand for continuous surveillance and early diagnosis in both clinical and home-care settings.